Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Tevogen Bio Inc

< Previous 1 2 3 4 Next >
Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company’s Mission of Health Equity
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.